Ambulero
Randy Berholtz is on the Board of Advisors at Ambulero.
Randy has executive-level positions at Innovus Pharmaceuticals, Apricus Biosciences, ACON laboratories, Nanogen, Inglewood Ventures, LP, Ventac Partners LLC, San Diego.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Ambulero
Ambulero is a cell and gene therapy spin-out of the University of Miami focused on advancing new therapies to fight vascular disease. A platform company that can deliver the adhesion molecule E-selectin using different cell and synthetic vector technologies.